If you own intellectual property, there’s a good chance you’re overlooking value—not because the IP isn’t useful, but because it doesn’t fit neatly into your current priorities.
You may be thinking:
- “This is interesting, but it’s not central to our strategy right now.”
- “We don’t have the bandwidth to pursue this.”
- “We’ll come back to it later.”
Later, of course, often means never.
A real-world licensing deal shows how smart companies avoid that trap—and how you can too.
The Real-World Example: Merck and Jiangsu Hengrui
Merck entered into a licensing agreement with Jiangsu Hengrui Pharmaceuticals to access rights outside China to a cardiovascular drug candidate developed by Hengrui.
This wasn’t a headline-grabbing acquisition.
And it wasn’t a signal that Merck was shifting its strategic focus.
Instead, it was a clear example of something far more common—and far more relevant to you:
Licensing used to unlock value from assets that aren’t core priorities.
The Situation You May Be In Right Now
If you’re honest, you may already recognize this pattern in your own portfolio.
You might own IP that:
- Has clear technical or commercial value
- Serves a market adjacent to your main focus
- Would require new teams, capital, or expertise to pursue
- Keeps getting pushed down the priority list
That doesn’t mean the IP lacks value.
It means it may belong outside your operating focus.
Merck faces this reality on a massive scale. You face it at a smaller one—but the strategic logic is exactly the same.
How Non-Core Licensing Actually Works
Licensing non-core IP is not about giving something away.
It’s about making a disciplined decision:
“This asset can create value—but not inside our current structure.”
In Merck’s case:
- The licensed asset represented opportunity
- But not enough to justify pulling internal resources
- Or reshaping pipeline priorities
Licensing allowed value creation to continue—without distraction.
For you, this can mean:
- Letting another company pursue markets you don’t want to enter
- Generating revenue from IP that would otherwise sit idle
- Preserving focus on what actually drives your business
Why This Strategy Is So Often Missed
Many IP owners hesitate to license non-core assets because:
- It feels like admitting the IP isn’t important
- There’s a fear that the asset could be more valuable later
- It’s emotionally hard to “let go”
But here’s the reality:
Unpursued IP doesn’t become more valuable over time. It becomes forgotten.
Licensing doesn’t eliminate upside—it often preserves it through:
- Royalties
- Milestone payments
- Rights reversion clauses
- Field-of-use or geographic limits
You stay connected to the asset without carrying the burden.
What This Means for You
If you own IP that:
- Isn’t aligned with your near-term strategy
- Requires capabilities you don’t want to build
- Competes for attention with higher-priority initiatives
Licensing can:
- Turn dormant IP into income
- Reduce opportunity cost
- Improve overall portfolio return
- Free you to focus on what you do best
This is not a retreat strategy.
It’s a focus strategy.
The Strategic Insight: Focus Creates More Value Than Control
One of the hardest shifts for IP owners is realizing that:
Owning IP doesn’t mean you have to operate it.
The most effective organizations don’t try to do everything. They decide where to concentrate—and license the rest.
Licensing non-core IP is a sign of strategic maturity, not weakness.
How Licensing Consulting Group Helps You Identify and Monetize Non-Core IP
The hardest part of this strategy is often identifying what’s truly non-core—and what’s quietly valuable.
Licensing Consulting Group (LCG) helps IP owners like you:
- Review IP portfolios to surface underutilized assets
- Evaluate secondary markets and applications
- Identify companies already positioned to execute
- Design outbound licensing strategies
- Support discussions through deal execution
The goal is simple: extract more value from what you already own—without changing your business model.
Ask Yourself This
Take a moment and ask:
- What IP do we own that we’re not actively pursuing?
- Is it non-core—or just neglected?
- Could someone else extract value from this faster than we could?
Those are the same questions companies like Merck answer every day.
Take the Next Step
If you suspect there’s untapped value sitting in your IP portfolio, licensing may be the cleanest way to unlock it.
👉 Schedule a Licensing Strategy Call with Licensing Consulting Group
We’ll review your IP, identify potential non-core opportunities, and discuss whether licensing makes strategic sense.
Stay Informed on Real-World Licensing Strategies
Licensing isn’t just about deals—it’s about decisions.
📩 Subscribe to the Licensing Consulting Group Newsletter to receive:
- Real-world licensing deal breakdowns
- Practical IP monetization strategies
- Insights from active outbound licensing campaigns
This article is part of our ongoing series analyzing real licensing deals—one strategy at a time—written for IP owners who want practical, executable guidance.
Rand Brenner is an IP professional whose passion is helping inventors, startups, and businesses use licensing to turn their IP into income-producing products, services, and technologies. His decades of experience run the gamut from medical devices to food technology to consumer products. He’s licensed some of the biggest Hollywood entertainment blockbusters, including the Batman Movies (1 and 2) and the number one kid’s action TV show, the Mighty Morphin Power Rangers. Rand speaks about licensing and is a featured speaker at investment conferences, trade shows, colleges, and startup events. His first book, Hidden Wealth: The Money-Making Power of Licensing, was released in 2019 and is available on Amazon.com. He’s also a published writer, and his articles have appeared in several prestigious trade magazines, including The Licensing Journal, Intellectual Property Magazine, and License India.
Working Through a Licensing or Commercialization Challenge?
If you have market-ready intellectual property, a licensing campaign that has stalled, or a business opportunity that may benefit from licensing, a short strategy discussion can help clarify the next step.